| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. – November 10, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended September 30, ... |
| 29 Oct 2026 |
8-K: Other Events
REDWOOD CITY, Calif., October 29, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors (the “Special Committee”) ... |
| 18 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. – August 11, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended June 30, 2026. |
| 31 Jul 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge Parkway, Redwood City, CA 94065 |
| 31 Jul 2026 |
8-K: Other Events
Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge ParkwayRedwood City, CA 94065 |
| 20 Jul 2026 |
8-K: Other Events
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. |
| 02 Jul 2026 |
8-K: Other Events
Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge Parkway, Redwood City, CA 94065 |
| 22 May 2026 |
8-K: Other Events
REDWOOD CITY, Calif., May 21, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the “Board”) has thoroughly reviewed and unanimously reje... |
| 13 May 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. – May 13, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended March 31, 2026. |
| 04 May 2026 |
8-K: Other Events
Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer’s Proteograph® Product Suite |
| 27 Apr 2026 |
8-K: Other Events
Board Determines Proposal Significantly Undervalues Seer and Is Not in the Best Interests of Stockholders |
| 13 Apr 2026 |
8-K: Other Events
REDWOOD CITY, Calif. – April 13, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that it has received a highly contingent, non-binding and... |
| 30 Mar 2026 |
8-K: Other Events
23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer's Proteograph® Product Suite |
| 16 Mar 2026 |
8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders
This Amendment No. 1 to Tax Benefit Preservation Plan (this “Amendment”) is dated as of March 13, 2026 (the “Effective Date”), and amends the Tax Benefit Preservation Plan, dated as of February 26, 2026 (the “Plan”), between Seer, Inc., ... |
| 26 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more
Exhibit A Form of Certificate of Designation of Rights, Powers and Preferences of Series A Participating Preferred Stock |
| 26 Feb 2026 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. February 26, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourth quarter and full year ended December 31, 2025. |
| 12 Dec 2025 |
8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
Pursuant to Section 243(b) of the General Corporation Law of the State of Delaware |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
REDWOOD CITY, Calif. November 6, 2025 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025. |
| 05 Sep 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
REDWOOD CITY, Calif., Sept. 2, 2025 -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board of Directors. |
Loading...